Postmenopausal testosterone therapy and breast cancer risk.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Maturitas

• Publication date

  2004-12-10

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.MATURITAS.2004.06.020PMID 15531122
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Aromatase in breast cancer tissue — localization and relationship with reproductive status of patients

  2005cited by this paper
• Oestrogen only arm of women's health initiative trial is stopped

  2004cited by this paper
• Oestrogen only arm of women's health initiative trial is stopped.

  2004cited by this paper
• Breast cancer and hormone-replacement therapy in the Million Women Study.

  2003cited by this paper
• Cancer prevalence in the UK: results from the EUROPREVAL study.

  2003cited by this paper
• Influence of Estrogen Plus Progestin on Breast Cancer and Mammography in Healthy Postmenopausal Women: The Women's Health Initiative Randomized Trial

  2003cited by this paper
• Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized Trial.

  2003cited by this paper
• Plasma sex steroid hormones and breast cancer risk in Chinese women

  2003cited by this paper
• A physiologic role for testosterone in limiting estrogenic stimulation of the breast

  2003cited by this paper
• Postmenopausal breast cancer risk in relation to sex steroid hormones, prolactin and SHBG (Sweden)

  2003cited by this paper
• Female androgen insufficiency: the Princeton consensus statement on definition, classification, and assessment.

  2002cited by this paper
• Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies.

  2002cited by this paper
• Testosterone and 5 alpha-dihydrotestosterone inhibit in vitro growth of human breast cancer cell lines.

  2002cited by this paper
• Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial.

  2002cited by this paper
• Aromatization of androgens in women: current concepts and findings.

  2002cited by this paper
• Breast cancer: from estrogen to androgen receptor

  2002cited by this paper
• Androgen production in women.

  2002cited by this paper
• Annual Report to the Nation on the status of cancer, 1973–1999, featuring implications of age and aging on U.S. cancer burden

  2002cited by this paper
• Randomized clinical trials of combined estrogen-androgen preparations: effects on sexual functioning.

  2002cited by this paper
• Testosterone and 5α-dihydrotestosterone inhibit in vitro growth of human breast cancer cell lines

  2002cited by this paper
• The potential role of estrogen in aromatase regulation in the breast.

  2001cited by this paper
• Transdermal testosterone treatment in women with impaired sexual function after oophorectomy.

  2000cited by this paper
• Testosterone inhibits estrogen‐induced mammary epithelial proliferation and suppresses estrogen receptor expression

  2000cited by this paper
• Sex hormone-induced mammary carcinogenesis in the female Noble rats: Expression of Bcl-2 and Bax in hormonal mammary carcinogenesis

  2000cited by this paper
• Effects of an Oral Contraceptive Combination With or Without Androgen on Mammary Tissues: A Study in Rats

  2000cited by this paper
• The role of local estrogen biosynthesis in males and females.

  2000cited by this paper
• Techniques to measure testosterone in the elderly.

  2000cited by this paper
• The effect of estrogen on aromatase and vascular endothelial growth factor messenger ribonucleic acid in the normal nonhuman primate mammary gland.

  1999cited by this paper
• Proapoptotic effects of antiestrogens, progestins and androgen in breast cancer cells.

  1999cited by this paper
• Androgens down-regulate bcl-2 protooncogene expression in ZR-75-1 human breast cancer cells.

  1999cited by this paper
• Elevated Serum Estradiol and Testosterone Concentrations Are Associated with a High Risk for Breast Cancer

  1999cited by this paper
• Sex hormone-induced mammary carcinogenesis in female noble rats: the role of androgens.

  1999cited by this paper
• Use of combined estrogen-androgen preparations in the postmenopause: evidence from clinical studies.

  1998cited by this paper
• Plasma sex steroid hormone levels and risk of breast cancer in postmenopausal women.

  1998cited by this paper
• Relation of serum levels of testosterone and dehydroepiandrosterone sulfate to risk of breast cancer in postmenopausal women.

  1997cited by this paper
• Estrogen sensitivity of normal human breast tissue in vivo and implanted into athymic nude mice: Analysis of the relationship between estrogen-induced proliferation and progesterone receptor expression

  1997cited by this paper
• A prospective study of endogenous serum hormone concentrations and breast cancer risk in post-menopausal women on the island of Guernsey.

  1997cited by this paper
• A prospective study of endogenous serum hormone concentrations and breast cancer risk in premenopausal women on the island of Guernsey.

  1997cited by this paper
• Association of Stein‐Leventhal syndrome with the incidence of postmenopausal breast carcinoma in a large prospective study of women in Iowa

  1997cited by this paper
• Serum sex hormone levels after menopause and subsequent breast cancer.

  1996cited by this paper
• Serum Steroid Hormone Levels, Sex Hormone‐Binding Globulin, and Body Mass Index in the Etiology of Postmenopausal Breast Cancer

  1996cited by this paper
• Concentrations of estrone, estradiol, and estrone sulfate and evaluation of sulfatase and aromatase activities in pre- and postmenopausal breast cancer patients.

  1996cited by this paper
• Cell death signal transduction and Bcl-2 function.

  1996cited by this paper
• Relation of prediagnostic serum estrogen and androgen levels to breast cancer risk.

  1996cited by this paper
• Medroxyprogesterone acetate therapy in advanced breast cancer: the predictive value of androgen receptor expression.

  1995cited by this paper
• Androgens induce divergent proliferative responses in human breast cancer cell lines.

  1995cited by this paper
• The proliferation of normal human breast tissue implanted into athymic nude mice is stimulated by estrogen but not progesterone.

  1995cited by this paper
• Testosterone enhances estradiol's effects on postmenopausal bone density and sexuality.

  1995cited by this paper
• Effects of tamoxifen on growth and apoptosis of estrogen-dependent and -independent human breast cancer cells

  1995cited by this paper
• Circulating levels of cytokines that modulate bone resorption: Effects of age and menopause in women

  1994cited by this paper
• 5-En-androstene-3 beta,17 beta-diol inhibits the growth of MCF-7 breast cancer cells when oestrogen receptors are blocked by oestradiol.

  1994cited by this paper
• Competitive reverse transcription-polymerase chain reaction analysis indicates that levels of aromatase cytochrome P450 transcripts in adipose tissue of buttocks, thighs, and abdomen of women increase with advancing age.

  1994cited by this paper
• Effect of tamoxifen on Ki67 labelling index in human breast tumours and its relationship to oestrogen and progesterone receptor status.

  1993cited by this paper
• Androgen and estrogen dynamics: relationships with age, weight, and menopausal status.

  1993cited by this paper
• Increase of plasma IL-6 concentration with age in healthy subjects.

  1992cited by this paper
• Sex hormones and postmenopausal breast cancer: a prospective study in an adult community.

  1992cited by this paper
• Aromatase activity and estradiol in human breast cancer: its relationship to estradiol and epidermal growth factor receptors and to tumor-node-metastasis staging.

  1992cited by this paper
• Effects of sex steroids on skin 5 alpha-reductase activity in vitro.

  1991cited by this paper
• Programmed cell death during regression of the MCF-7 human breast cancer following estrogen ablation.

  1991cited by this paper
• Additive inhibitory effects of an androgen and the antiestrogen EM-170 on estradiol-stimulated growth of human ZR-75-1 breast tumors in athymic mice.

  1991cited by this paper
• Serum and urinary androgens and risk of breast cancer in postmenopausal women.

  1991cited by this paper
• Polycystic ovaries and the risk of breast cancer.

  1991cited by this paper
• Oestrogen and androgen states in oligo‐amenorrhoeic women with polycystic ovaries

  1991cited by this paper
• Dehydroepiandrosterone sulfate and breast cancer risk.

  1990cited by this paper
• Androgens and breast cancer in premenopausal women.

  1989cited by this paper
• Inhibitory effect of androgens on DMBA-induced mammary carcinoma in the rat

  1989cited by this paper
• Affective changes with estrogen and androgen replacement therapy in surgically menopausal women.

  1988cited by this paper
• Influence of non‐contraceptive exogenous and endogenous sex hormones on breast cancer risk in Denmark

  1988cited by this paper
• Effect of combined implants of oestradiol and testosterone on libido in postmenopausal women.

  1987cited by this paper
• Sex hormone levels in serum in relation to the development of breast cancer.

  1987cited by this paper
• Menopausal oestrogens and breast cancer risk: an expanded case-control study.

  1986cited by this paper
• Prolactin modulates peripheral androgen metabolism.

  1986cited by this paper
• Effects of aging and obesity on aromatase activity of human adipose cells.

  1985cited by this paper
• The effect of spironolactone on genital skin 5α-reductase activity

  1985cited by this paper
• Inhibition of androgen metabolism in stroma and epithelium of the human benign prostatic hyperplasia by progesterone, estrone, and estradiol

  1985cited by this paper
• Androgen enhances sexual motivation in females: a prospective, crossover study of sex steroid administration in the surgical menopause.

  1985cited by this paper
• Differential symptom response to parenteral estrogen and/or androgen administration in the surgical menopause.

  1985cited by this paper
• The effect of spironolactone on genital skin 5 alpha-reductase activity.

  1985cited by this paper
• The management of persistent menopausal symptoms with oestradiol-testosterone implants: clinical, lipid and hormonal results.

  1984cited by this paper
• The effect of five synthetic progestational compounds on 5 alpha-reductase activity in genital skin fibroblast monolayers.

  1984cited by this paper
• Chronic Anovulation Syndrome and Associated Neoplasia

  1983cited by this paper
• An antiestrogenic action of androgens in human breast cancer cells.

  1981cited by this paper
• Treatment of hirsutism by oral cyproterone acetate and percutaneous estradiol.

  1980cited by this paper

• Beyond Prostate Cancer: An Androgen Receptor Splice Variant Expression in Multiple Malignancies, Non-Cancer Pathologies, and Development

  2023cites this paper
• What is the Role of Testosterone Therapy in Postmenopausal Women? A SWOT Analysis

  2023cites this paper
• Androgen Therapy in Women with Testosterone Insufficiency: Looking Back and Looking Ahead

  2022cites this paper
• Androgen therapy for women after menopause.

  2021cites this paper
• High prevalence of benign mammary tumors in a rat model of polycystic ovary syndrome during postmenopausal period

  2019cites this paper
• Comparative evaluation of selected sex hormones in premenopausal and postmenopausal women with breast cancer

  2019cites this paper
• Androgênios e mama

  2017cites this paper
• The Case for Androgens in Menopausal Women: When and How?

  2017cites this paper
• Essentials of Menopause Management

  2017cites this paper
• Breast Cancer and Postmenopausal Obesity: the Risk Factors in this Relationship

  2014cites this paper
• Combined conjugated esterified estrogen plus methyltestosterone supplementation and risk of breast cancer in postmenopausal women.

  2014cites this paper
• Examining the Role of DAX-1 in Regulation of Cell Proliferation in Human Breast Cells

  2014cites this paper
• The Effects of Estradiol, Androgens and the Selective Estrogen Modulators: Ospemifene, Raloxifene and Tamoxifen on Explant Cultures of Human Breast Tissue

  2013cites this paper
• Androgens inhibit the stimulatory action of 17β-estradiol on normal human breast tissue in explant cultures.

  2012cites this paper
• Efficacy and safety of testosterone in the management of hypoactive sexual desire disorder in postmenopausal women.

  2012cites this paper
• Androgens Inhibit the Stimulatory Action of 17 (cid:1) -Estradiol on Normal Human Breast Tissue in Explant Cultures

  2012cites this paper
• Minimally invasive gynecologic procedures

  2011cites this paper
• Low-dose testosterone treatment decreases oxidative damage in TM3 Leydig cells.

  2011cites this paper
• Androgen receptor genotypes predict response to endocrine treatment in breast cancer patients

  2011cites this paper
• DHEA, Androgen Receptors and Their Potential Role in Breast Cancer

  2011cites this paper
• Amelioration of sexual adverse effects in the early breast cancer patient

  2010cites this paper
• Circulating Steroid Hormone Levels and Risk of Breast Cancer for Postmenopausal Women

  2010influential citation
• Endocrine aspects of women's sexual function.

  2010cites this paper
• Increased intratumoral androgens in human breast carcinoma following aromatase inhibitor exemestane treatment.

  2010cites this paper
• Study of adverse outcomes in women using testosterone therapy

  2009cites this paper
• Selected testosterone‐related diseases in women who have given birth to a child with infantile autism

  2009cites this paper
• Study of adverse outcomes in women using testosterone therapy.

  2009cites this paper
• Testosterone reduces cumulative burying in female Wistar rats with minimal participation of estradiol.

  2009cites this paper
• Testosterone replacement therapy in naturally and surgically menopausal women.

  2009cites this paper
• Androgens act synergistically to enhance estrogen‐induced upregulation of human tissue kallikreins 10, 11, and 14 in breast cancer cells via a membrane bound androgen receptor

  2008cites this paper
• Breast cancer risk in postmenopausal women using testosterone in combination with hormone replacement therapy.

  2008cites this paper
• Lack of expression of androgen receptor may play a critical role in transformation from in situ to invasive basal subtype of high-grade ductal carcinoma of the breast.

  2008cites this paper
• Testosterone and the postmenopausal breast : Aspects on cell proliferation and mammographic density

  2008cites this paper
• Testosterone inhibits estrogen/progestogen-induced breast cell proliferation in postmenopausal women

  2007cites this paper
• Androgens and the breast.

  2007cites this paper
• Emerging Role of Testosterone in Menopause

  2007cites this paper
• 5α‐Reductase type 1 and aromatase in breast carcinoma as regulators of in situ androgen production

  2007cites this paper
• Testosterone treatment for hypoactive sexual desire disorder in postmenopausal women.

  2007cites this paper
• Elevated rates of testosterone-related disorders in women with autism spectrum conditions.

  2007cites this paper
• Effects of Long-term Androgen Administration on Breast Tissue of Female-to-Male Transsexuals

  2006influential citation
• Testosterone therapy for postmenopausal women: efficacy and safety.

  2006influential citation
• Synthesis of Nitric Oxide in Human Osteoblasts in Response to Physiologic Stimulation of Electrotherapy

  2006cites this paper
• Androgen Receptor and Prostate-Specific Antigen Gene Polymorphisms and Breast Cancer in African-American Women

  2005cites this paper